Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01538810 · ClinicalTrials.gov registry record
Biomarker Correlates of Radiologic Imaging
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 751
- Enrollment target
NCT01538810: Completed study, sponsored by Washington University School of Medicine.
NCT01538810 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 751 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01538810 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 751 participants
- Enrollment target
Study Summary
The purpose of this study is to assemble a collection of urine and blood samples for the development and validation of biomarkers potentially useful in correlating or improving the diagnostic utility of abdominal imaging.
Primary Outcome
Confirm the ability of quantitative measure of AQP-1 and ADFP by ELISA from urine and blood samples to develop and validate an assay for patients with renal cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 751 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-05 |
What the finished NCT01538810 record still lists
NCT01538810 is an observational study that tracks outcomes without assigning an intervention. The registered 751 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01538810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01538810 about?
NCT01538810 is a clinical study titled "Biomarker Correlates of Radiologic Imaging". The purpose of this study is to assemble a collection of urine and blood samples for the development and validation of biomarkers potentially useful in correlating or improving the diagnostic utility of abdominal imaging.
What is the current status of trial NCT01538810?
This trial is currently completed. The enrollment target is 751 participants. The study started on 2012-02. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT01538810?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06559306 · 752 participants · Phase 3
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia